Annals of Internal Medicine

Papers
(The H4-Index of Annals of Internal Medicine is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Attitudes Toward a Potential SARS-CoV-2 Vaccine941
Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths814
Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study590
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors530
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19462
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization422
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic414
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series280
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers270
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia260
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2257
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19229
Depression229
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building194
Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic187
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate187
Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China169
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection167
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings164
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs155
Patient Trajectories Among Persons Hospitalized for COVID-19153
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020147
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness139
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?135
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults133
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments128
Firearm Purchasing During the COVID-19 Pandemic: Results From the 2021 National Firearms Survey128
Racial Disparities in COVID-19 Testing and Outcomes128
QUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies126
Myasthenia Gravis Associated With SARS-CoV-2 Infection126
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles122
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France121
Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants120
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States116
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline116
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update113
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings111
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis110
Insomnia110
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities109
Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine109
Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults108
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting107
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System107
A SARS-CoV-2 Cluster in an Acute Care Hospital106
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting101
Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020100
Worsening Spread of Candida auris in the United States, 2019 to 202199
A Novel International Monkeypox Outbreak98
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 202197
Type 1 Diabetes Mellitus95
Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series95
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity93
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt93
Pulmonary Hypertension93
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans92
The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries90
Characteristics, Outcomes, and Trends of Patients With COVID-19–Related Critical Illness at a Learning Health System in the United States90
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose89
Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine87
Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-1987
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-1985
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population85
Insights From Rapid Deployment of a “Virtual Hospital” as Standard Care During the COVID-19 Pandemic84
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus83
Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients82
Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons?79
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials79
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV79
Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities78
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors77
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism76
Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System75
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial75
Every Body Counts: Measuring Mortality From the COVID-19 Pandemic75
0.033299922943115